| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
| (30) |
Priority: |
14.04.2014 DK 201470212
|
| (43) |
Date of publication of application: |
|
22.02.2017 Bulletin 2017/08 |
| (73) |
Proprietor: Cellectis |
|
75013 Paris (FR) |
|
| (72) |
Inventor: |
|
- GALETTO, Roman
F-75014 Paris (FR)
|
| (74) |
Representative: Zacco Denmark A/S |
|
Arne Jacobsens Allé 15
2300 Copenhagen S
2300 Copenhagen S (DK) |
| (56) |
References cited: :
WO-A1-2012/079000
WO-A1-2013/154760
|
WO-A1-2013/072406
|
|
| |
|
|
- GARFALL ALFRED L ET AL: "Immunotherapy with chimeric antigen receptors for multiple
myeloma.", DISCOVERY MEDICINE JAN 2014, vol. 17, no. 91, January 2014 (2014-01), pages
37-46, XP009181586, ISSN: 1944-7930
- CARPENTER R O ET AL: "B-cell Maturation Antigen Is a Promising Target for Adoptive
T-cell Therapy of Multiple Myeloma", CLINICAL CANCER RESEARCH, THE AMERICAN ASSOCIATION
FOR CANCER RESEARCH, US, vol. 19, no. 8, 15 April 2013 (2013-04-15) , pages 2048-2060,
XP002727959, ISSN: 1078-0432, DOI: 10.1158/1078-0432.CCR-12-2422 [retrieved on 2013-01-23]
- FINNEY HELENE M ET AL: "Activation of resting human primary T cells with chimeric
receptors: Costimulation from CD28, inducible costimulator, CD134, and CD137 in series
with signals from the TCRzeta chain", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION
OF IMMUNOLOGISTS, US, vol. 172, no. 1, 1 January 2004 (2004-01-01), pages 104-113,
XP002420497, ISSN: 0022-1767
- JENSEN MICHAEL C ET AL: "Design and implementation of adoptive therapy with chimeric
antigen receptor-modified T cells", IMMUNOLOGICAL REVIEWS, vol. 257, no. 1, Sp. Iss.
SI, January 2014 (2014-01), pages 127-144, XP055156740,
- DAVID L PORTER ET AL: "Chimeric Antigen Receptor Therapy for B-cell Malignancies",
JOURNAL OF CANCER, vol. 2042127, 1 January 2011 (2011-01-01), page 331, XP055118200,
ISSN: 1837-9664, DOI: 10.7150/jca.2.331
|
|
